1220695-06-6 Usage
Description
Cyclobutylmethanesulfonyl chloride is an organic compound with the chemical formula C5H9ClO2S. It is a synthetic reagent used in the field of medicinal chemistry and pharmaceuticals, particularly for the synthesis of various biologically active molecules.
Uses
Used in Pharmaceutical Industry:
Cyclobutylmethanesulfonyl chloride is used as a synthetic reagent for the preparation of tetrahydropyrrole compounds. These compounds serve as inhibitors for D2 receptors and DAT (Dopamine Active Transport) receptors, which are important targets in the treatment of various neurological and psychiatric disorders, such as schizophrenia, bipolar disorder, and Parkinson's disease. The application of cyclobutylmethanesulfonyl chloride in this context is due to its ability to facilitate the formation of these biologically active molecules, potentially leading to the development of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1220695-06-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,0,6,9 and 5 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1220695-06:
(9*1)+(8*2)+(7*2)+(6*0)+(5*6)+(4*9)+(3*5)+(2*0)+(1*6)=126
126 % 10 = 6
So 1220695-06-6 is a valid CAS Registry Number.
1220695-06-6Relevant articles and documents
8-Substituted isoquinoline derivative and the use thereof
-
Page/Page column 121; 122, (2010/11/03)
The present invention relates to a compound represented by the following formula (1): wherein D1, A1, D2, R1, D3, and R2 each have the same meaning as defined in the present specification or a salt thereof. The compound represented by the formula (1) or a salt thereof has an IKKβ inhibiting activity and the like and is useful for the prevention and/or treatment of IKKβ-associated diseases or symptoms and the like.
MACROCYCLIC PEPTIDES AS HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 63, (2008/12/05)
Macrocyclic peptides having the general formula (I): are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Inhibitors of Hepatitis C Virus
-
, (2008/12/04)
Macrocyclic peptides are disclosed having the general formula: wherein R3, R′3, R4, R6, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
